Patent directory · USPTO A61K / A61P
Patents matching “Nanjing Legend Biotech Co., Ltd”
16 pharma patents match "Nanjing Legend Biotech Co., Ltd" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 16 pharmaceutical patents matching "Nanjing Legend Biotech Co., Ltd" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12258418
Claudin18.2 binding moieties and uses thereof
granted -
US 12168688
Antibodies and variants thereof against PD-L1
granted -
US 11958903
Single-domain antibodies against LAG-3 and uses thereof
granted -
US 11932698
Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof
granted -
US 11905327
Single-domain antibodies and variants thereof against TIGIT
granted -
US 11827713
Chimeric antibody immune effector cell engagers and methods of use thereof
granted -
US 11713353
Single-domain antibodies and variants thereof against PD-1
granted -
US 11708410
Antibodies and variants thereof against TIGIT
granted -
US 11673954
Single-domain antibodies and variants thereof against PD-L1
granted -
US 11564945
Chimeric antigen receptor and use thereof
granted -
US 11505601
Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum
granted -
US 11472881
Single-domain antibodies and variants thereof against CTLA-4
granted -
US 11447573
Multispecific antigen binding proteins and methods of use thereof
granted -
US 11401317
Human-CD123-targeting chimeric receptor ligand and application thereof
granted -
US 11168146
Compositions and methods for increasing protein half-life in a serum
granted -
US 10407508
Compositions and methods for increasing protein half-life in a serum
granted